Acquisition of exclusive manufacturing and marketing rights for DOTATOC
- In-licensing of superior DOTA-Tyr3-octreotide
- Pharmaceutical development for treatment of NETs
- Excellent pharmacokinetic properties
- Pharmaceutical development for treatment of NETs
- Excellent pharmacokinetic properties